ASO Author Reflections: TNM 8th Edition: Stage I Non-small Cell Lung Cancer-Free from Recurrence and Adjuvant Therapy? How to Predict?

Yuan Zeng^{1

2}, Nicholas Mayne³, Chi-Fu Jeffrey Yang³, Wenhua Liang^{4

5}, Jianxing He^{6

7}

Affiliations

¹ Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
² Guangzhou Institute of Respiratory Disease and China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong Province, People's Republic of China.
³ Section of General Thoracic Surgery, Duke University Medical Center, Durham, NC, USA.
⁴ Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. liangwh1987@163.com.
⁵ Guangzhou Institute of Respiratory Disease and China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong Province, People's Republic of China. liangwh1987@163.com.
⁶ Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. drhe_jianxing@163.com.
⁷ Guangzhou Institute of Respiratory Disease and China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong Province, People's Republic of China. drhe_jianxing@163.com.

Comment

Yuan Zeng et al. Ann Surg Oncol. 2019 Dec.

. 2019 Dec;26(Suppl 3):745-746.

doi: 10.1245/s10434-019-07856-0. Epub 2019 Sep 25.

Yuan Zeng^{1

2}, Nicholas Mayne³, Chi-Fu Jeffrey Yang³, Wenhua Liang^{4

5}, Jianxing He^{6

7}

¹ Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China.
² Guangzhou Institute of Respiratory Disease and China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong Province, People's Republic of China.
³ Section of General Thoracic Surgery, Duke University Medical Center, Durham, NC, USA.
⁴ Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. liangwh1987@163.com.
⁵ Guangzhou Institute of Respiratory Disease and China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong Province, People's Republic of China. liangwh1987@163.com.
⁶ Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China. drhe_jianxing@163.com.
⁷ Guangzhou Institute of Respiratory Disease and China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, Guangdong Province, People's Republic of China. drhe_jianxing@163.com.

No abstract available

Comment on

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. Goldstraw P, et al. J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009. J Thorac Oncol. 2016. PMID: 26762738